AngioDynamics Appoints Richard C. Rosenzweig (’92) Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Richard C. Rosenzweig (’92) as Senior Vice President, General Counsel, effective January 31, 2021. Mr. Rosenzweig will also serve as Corporate Secretary to the AngioDynamics Board of Directors.
Mr. Rosenzweig succeeds Stephen Trowbridge who has served as Executive Vice President, Chief Financial Officer, and General Counsel since February 2020. Mr. Trowbridge will continue in his role as Executive Vice President and Chief Financial Officer.